
Sign up to save your podcasts
Or


On this episode of Stock Movers:
- Oracle (ORCL) surged to a record after the company gave an aggressive outlook for its cloud business, stunning Wall Street and galvanizing hopes that the post-ChatGPT global AI infrastructure build-out is accelerating. Oracle's cloud infrastructure revenue increased 55% to $3.3 billion, with the company signing four multibillion-dollar contracts with three different customers in the quarter and expecting to sign up several additional customers in the coming months.
- Synopsis (SNPS) shares are sinking after warning that US export restrictions are contributing to a slowdown in China. Its price target was also cut at Stifel, Wells Fargo, and KeyBanc. The electronic design automation software company reported third-quarter results that featured a weak read on Design IP revenue. It also gave an earnings outlook that was weaker than expected.
- Novo Nordisk (NVO) shares are up after it announced it will slash 9,000 jobs globally and cut its profit forecast for the third time this year as it fights to recover ground lost to its rival Eli Lilly & Co. in the obesity drug market.
See omnystudio.com/listener for privacy information.
By iHeartPodcasts4.6
1919 ratings
On this episode of Stock Movers:
- Oracle (ORCL) surged to a record after the company gave an aggressive outlook for its cloud business, stunning Wall Street and galvanizing hopes that the post-ChatGPT global AI infrastructure build-out is accelerating. Oracle's cloud infrastructure revenue increased 55% to $3.3 billion, with the company signing four multibillion-dollar contracts with three different customers in the quarter and expecting to sign up several additional customers in the coming months.
- Synopsis (SNPS) shares are sinking after warning that US export restrictions are contributing to a slowdown in China. Its price target was also cut at Stifel, Wells Fargo, and KeyBanc. The electronic design automation software company reported third-quarter results that featured a weak read on Design IP revenue. It also gave an earnings outlook that was weaker than expected.
- Novo Nordisk (NVO) shares are up after it announced it will slash 9,000 jobs globally and cut its profit forecast for the third time this year as it fights to recover ground lost to its rival Eli Lilly & Co. in the obesity drug market.
See omnystudio.com/listener for privacy information.

406 Listeners

1,173 Listeners

2,175 Listeners

1,993 Listeners

427 Listeners

1,044 Listeners

1,320 Listeners

65 Listeners

64 Listeners

155 Listeners

87 Listeners

80 Listeners

81 Listeners

9 Listeners

11 Listeners